Calling 3 Phase 2 trials, across 3 separate drug platforms that are now finished, no failures, and waiting for top line data before considering a partnership offer, calling that a “Hail Mary” pass is about as misleading a post as possible without the post being an outright lie. As of the release of data showing efficacy, for each drug there is a 58% chance to succeed to completion of its progress to approval. That includes the risks of Phase 3. Taken together there will be a 98% chance of approval for just one.
Since you are using a football metaphor, if there was a 98% of completing a pass for touchdown every time Tom Brady threw a “Hail Mary”, he would have won every season’s playoff berth and every Super Bowl of his career, except for those seasons where he was out due to injury, of course.
News 
Market Data 
Discover 
